Headmedi-N 250 Tablet is a combination medication containing Naproxen 250 mg and Domperidone 10 mg, formulated to provide effective relief from pain and associated gastrointestinal discomfort. Naproxen, a nonsteroidal anti-inflammatory drug (NSAID), exerts analgesic, anti-inflammatory, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis responsible for pain and inflammation. Domperidone, a dopamine D2 receptor antagonist, enhances gastrointestinal motility and accelerates gastric emptying, which helps alleviate nausea and vomiting often associated with pain or NSAID therapy. This combination is commonly prescribed for conditions such as musculoskeletal pain, dysmenorrhea, and inflammatory disorders where pain relief is required alongside management of gastrointestinal side effects. Headmedi-N 250 should be used under medical supervision, with caution advised in patients with a history of peptic ulcers, cardiovascular disease, or hepatic impairment. It is contraindicated in individuals with hypersensitivity to either component and should be avoided during pregnancy and lactation unless deemed necessary by a healthcare professional. Common adverse effects may include gastrointestinal discomfort, dizziness, and dry mouth. Patients are advised to follow prescribed dosages and report any unusual symptoms to their healthcare provider promptly.